The January 2020 Issue is now live!

Big changes for 2020- starting with a new design for the cover and increasing to monthly publication! 12 issues of JMD instead of 6! Click below to read now!

Nora Springer, DVM published in AJP

Congratulations to American Society for Investigative Pathology member Nora Springer on on having her article published in, & featured on the cover of, the Oct '19 issue of The American Journal of Pathology

Human diseases are exceptionally complex. Consider various forms of cancer, heart disease, diabetes, atherosclerosis, diseases of immunity, genetic diseases, infectious diseases, and many others. The causes of these disease processes are equally complex and almost always multifactorial, with contributions from the host/patient (related to genetics or physiology), various exposures to disease agents, factors from the environment, and many more. The patients themselves are complex and so the presentation, consequences, and severity of disease have a tendency to vary tremendously among an affected cohort. Despite recognition of these complexities associated with human disease, researchers have historically taken reductionists approaches to their study. Hence, our knowledge of many diseases reflect the combination of results (and inferences) from ex vivo approaches, in vitro cell culture, model systems, and examination of limited numbers of molecular mediators of disease. It has been recognized for many years that the complete understanding of any disease process will require the ability to examine the condition in the context of the patient, without elimination of the complexities of the in vivo condition. Welcome to the world of systems biology and network science!

AJP Issue Highlights:

Theme Issues DCIS Theme Issue Pancreatic Cancer Theme issue AJP Editor's Choice CD55 Is Essential for CD103+ Dendritic Cell Tolerogenic Responses that Protect against Autoimmunity CCN3/Nephroblastoma Overexpressed Is a Functional Mediator of Prostate Cancer Bone Metastasis That Is Associated with Poor Patient Prognosis Review Articles CD55 Is Essential for CD103+ Dendritic Cell Tolerogenic Responses that Protect against [...]